Source link : https://www.newshealth.biz/health-news/earlier-inclisiran-gives-better-long-term-ldl-reductions/
Cholesterol lowering with a strategy using the short interfering RNA agent, inclisiran, earlier in the treatment pathway led to significantly better long-term low-density lipoprotein (LDL) reduction compared with usual care in patients with atherosclerotic cardiovascular disease (ASCVD), in a new “real world” study. While most patients in the “inclisiran first” arm reached LDL goals at […]
Author : News Health
Publish date : 2024-04-17 08:02:21
Copyright for syndicated content belongs to the linked Source.